DEPDC5 and neoplasm: M60 presented additional pathogenic alterations of the DNA damage response (DDR) pathway, and F75 showed pathogenic mutations in multiple tumor suppressor genes, such as DEPDC5 p.W905*, an mTOR inhibitor [23], and several nuclear DNA effectors.